• INND purchased all assets and operations of iHEAR Medical, a venture-backed provider of FDA-cleared cloud-based hearing solutions
• Acquisition provides INDD access to over 40 patents developed by acquired company and opportunity to expand market reach by leveraging its distribution channels
• INND appears poised to position itself as leader in DTC hearing space; expects acquisition to rapidly expand Company’s sales and distribution capabilities

InnerScope Hearing Technologies (OTC: INND), a leading manufacturer and distributor of FDA-registered hearing products and Personal Sound Amplifier Products, has acquired all assets and operations of iHEAR Medical Inc. (“iHEAR”), a venture-backed pioneer in the online direct-to-consumer hearing solutions. InnerScope expects the acquisition to expand and solidify the Company’s position as the emerging leader in the market of direct-to-consumer and over-the-counter hearing products. Acquired assets include iHEAR’s FDA-Registered manufacturing facility, R&D center, and shipping operations in San Leandro, California (https://ibn.fm/3oM09). The California-based iHEAR has a demonstrated track record in bringing novel hearing solutions to the market. It boasts a team that holds more than 100 patents in miniature hearing electronics and medical devices. Often featured in major media outlets such as CNN, New York Times, Dr. Oz Show, USA Today and Inc. Magazine, iHEAR’s founders developed innovations that went on to receive significant recognition, including the Medical Device Excellence Award (https://ibn.fm/tJ7Ev). With a shared vision and mission to address the global demand for affordable hearing solutions, the two companies have compatible business models that can help InnerScope position itself as a leader in the direct-to-consumer hearing products market. In the words of Matthew Moore, President, and CEO of InnerScope, the transaction will allow InnerScope to unlock synergies and leverage this unparalleled access to cutting-edge innovation in the hearing products space. “The Acquisition of iHEAR Medical brings world-class innovation and access to over 40 patents in hearing technology,” he said. “Our alliance with iHEAR and its technology partners allow us to rapidly expand sales and distribution, particularly through pharmacies and insurance partners.” Through this acquisition, InnerScope will be able to broaden its product offering to include the only FDA-cleared home hearing screener, iHEARtest(TM), (FDA clears home hearing test) advanced FDA-registered hearing aids, and the TReO(TM) Personal Sound Amplification Product (“PSAP”). The transaction will also enable InnerScope to expand its market reach and leverage iHEAR’s established distribution channels to gain access to partners in retail and wholesale space as well as in insurance and direct online sales. Retail and wholesale partners include names such as CVS Pharmacy, Cardinal Health, AmerisourceBergen, Western States Pharmacy Coalition (“WSPC”), Good Neighbor Pharmacy, FSA Store and Amazon, while insurance partners include insurers such as VIA Benefits, Ameritas and Willis Towers Watson. In addition, the full range of iHEAR-branded products will remain available online at http://iheardirect.com. Following the acquisition, InnerScope has ambitious plans for the future. “Leveraging the renowned R&D talents of iHEAR Medical, InnerScope plans to develop next-generation hearing products incorporating artificial intelligence (“AI”), advanced sound processing for improved hearing in noise environments, and seamless wireless connectivity to Internet-Of-Things (“IoT”) devices,” stated Moore. Hearing loss affects around 5% of the global population, the vast majority of which remains untreated due to prohibitive barriers, such as high cost, complex dispensing processes, and lack of access to high-quality hearing products. But left untreated, hearing loss can be associated with a range of social, economic, and health problems. As a leading manufacturer and distributor of FDA-registered hearing products and Personal Sound Amplifier Products (“PSAPs”), InnerScope is dedicated to addressing the global demand for affordable hearing solutions. With the acquisition of iHEAR Medical, InnerScope appears well-positioned further to expand its leadership in the direct-to-consumer hearing solutions market. InnerScope launched its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com to consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs. For more information, visit the company’s website at www.INND.com and the company’s e-commerce website: www.MyHearIQ.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Blood and genomic testing are becoming preferable means of early cancer screening and detection
• Leaders innovating this niche of the medical industry include AnPac Bio, Grail, Thrive and Guardant
• AnPac Bio-Medical’s testing features a database of more than 200,000 commercial and research multi-cancer test samples (probably the largest multi-cancer test data base) that detect up to 26 different types of cancer
• One of the few companies offering multi-cancer tests for risk assessment and actually contributing to the fight against cancer by having its high risk individuals (tested first by its tests and later) confirmed in the healthcare providers for cancer patients and pre-cancer patients early

Almost 1.9 million new cancer cases will be diagnosed in the United States in 2021, according to American Cancer Society (“ACS”) estimates. This number excludes basal cell, squamous cell skin cancer, and carcinoma in situ except for urinary bladder cancer. The ACS also estimates that the number of Americans to die from cancer in 2021 will be 608,570, equivalent to 1,670 people per day (https://ibn.fm/qcO5q). To address these rising cancer rates, biotechnology companies in the U.S. and worldwide are focusing on the early detection and screening of cancer through the development of proprietary technologies. AnPac Bio-Medical Science The companies currently paving the way for early cancer screening and detection include AnPac Bio-Medical Science (NASDAQ: ANPC), Illumina, Inc.’s (NASDAQ: ILMN), Grail, Inc. (now part of Illumina), Exact Sciences Co., Ltd. (NASDAQ: EXAS), and Thrive Earlier Detection (now part of Exact Sciences), and Guardant Health (NASDAQ: GH). All four of these companies have developed blood and genomic tests that help detect and screen for early cancers, some of which have no other means of early detection. Powered by a database containing over 200,000 samples and cases, AnPac Bio’s Cancer Differentiation Analysis (“CDA”) is a proprietary novel technology for early cancer screening and detection. CDA technology can detect and carry multi-level information including cellular and protein level information to determine the existence of cancerous environments. At present, our CDA platform can detect up to 26 different types of cancer, which gives AnPac Bio a major advantage over industry peers in terms of cost effectiveness, multi-cancer testing, ability to detect cancer early with high sensitivity and specificity. With its proprietary technology and being one of the first companies in the world to introduce the concept of multi-level, multi-parameter and multi-cancer (pan-cancer) screening approaches, AnPac Bio is uniquely positioned to be a leader among other prominent cancer screening and detection blood testing companies currently on the market. The company has accredited clinical laboratories in the U.S. and China, and a total of 142 patents issued since the early 2010s, a significantly higher number of patents as compared to its industry peers (Grail has 80 patents https://ibn.fm/iQ09Q and Thrive has 1 filed patent https://ibn.fm/LOBXP). In 2019, a Frost & Sullivan report ranked AnPac Bio third in the world and first in China among those companies that offer next-generation early cancer screening and detection testing in terms of the number of clinical samples. Other Companies Thrive’s CancerSeek is a liquid biopsy blood test for the detection of cancer at its early stages. The results were published in a 2020 issue of Science, demonstrating that the blood test more than doubled the number of detected cancers, with 65% of these samples were at earlier stages, across ten cancer types, with seven of them having no recommended standard-of-care tests. Guardant Health reported recently at ASCO 2021 that its Lunar-2 colorectal cancer screening study achieved overall sensitivity of 91% in early-stage CRC detection (stage I, II, and III), and specificity of 94%. The ECLIPSE study will screen for colorectal cancer where they plan to enroll 10,000 people between the ages of 60-84 from across the United States by the end of 2021. Galleri(TM) is GRAIL’s trademarked cancer screening and detection blood test. This blood test can detect over 50 types of cancer, allowing patients to take control of their health and be proactive about cancer screening. This blood test is recommended for people ages 50 and older and is intended to be used in addition to other cancer screening tools recommended by a primary healthcare provider. Liquid biopsy-based noninvasive testing is leading the way for early cancer screening, detection and diagnosis, often preferable to other cancer testing methods. With an increase in cancer cases globally, early detection and screening is becoming prevalent across much of the healthcare industry. Worldwide, the cancer diagnostics market is expected to grow at a CAGR of 7% during the forecast period, resulting in a market value of $249.6 billion by 2026 (https://ibn.fm/aANDy). For more information, visit the company’s website at www.AnPacBio.com. NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

• Delic Holdings Corp. (the “company” or “Delic”) reported Q2 revenues of $149,290 while realizing a strong gross profit margin of 87%
• The company has recently broadened its business verticals through the acquisition of Homestead, a psychedelic media distributor, and Ketamine Infusion Centers LLC, one of the largest chains of ketamine clinics in the U.S.

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has recently published its second quarter results for the 2021 fiscal year. The company reported Q2 revenues of $149,290. Delic also reported second quarter gross profits of $130,129, resulting in an impressive 87% gross profit margin (https://ibn.fm/DZ5QQ). The company owns and operates a self-sustaining ecosystem of businesses in the psychedelic space consisting of media, science and health business verticals. Delic has been particularly active on the mergers and acquisition front over the last several months in a bid to further broaden the company’s business horizons. On June 30, 2021, the company acquired Ketamine Infusion Centers LLC (“KIC”), one of the largest ketamine clinics in the United States, for gross consideration of $3,040,312. In March, Delic successfully completed the acquisition of the brand and intellectual property of Homestead, a legacy counterculture distributor of psychedelic media and creator of one of the first self-contained mushroom grow kits. Moving forward, the Delic ecosystem will be centered across three primary pillars, namely — media, health and science. On the media front, the company will seek to nurture new audiences and educate the public on the latest developments within the psychedelic sector through a variety of digital platforms, including Delic’s Reality Sandwich digital magazine; Meet Delic, the first-ever psychedelic wellness summit to be based in Las Vegas and which attracted over 2,000 live attendees at its inaugural event; and Delic Radio, an online podcast program boasting over 43 episodes and upwards of 100 thousand total streams to date. Delic’s focus within the health sphere will be centered around the Ketamine Infusion Centers, an Arizona-based clinical chain with three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. The clinics, which have cumulatively overseen 4,000+ treatments delivered to date, have plans to scale and operate over 20 clinics, with a plan to operate 10 more clinics over the coming 18 months. On its Sept. 20 press release, Delic announced a merger with Arizona-based ketamine infusion clinic company Ketamine Wellness Centers Inc. KWC operates 10 clinics across multiple states, cementing Delic’s position as the largest ketamine health provider and psychedelic wellness chain in the country. “The Delic team is committed to making psychedelic wellness accessible to the masses, and with this chain of clinics and upcoming acquisitions, we are making that vision possible,” stated Matt Stang, Founder and CEO (https://ibn.fm/GIz2h). Lastly, the company’s science business will be focused around developing IP and advanced extraction and testing facilities, which form the backbone of the legal market. The company will center their efforts through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver and the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology. North America is currently blazing the path in advancing the psychedelic industry through a variety of forward-looking research projects, at a time when psychedelics are increasingly becoming accepted globally on the basis of their therapeutic, medical, and recreational use. With 32 million people in the U.S., or 17% of all American adults aged 21 to 64, having used psychedelics at least once, the industry seems to be well on its way to mainstream acceptance (https://ibn.fm/7K7YX). Through their various initiatives and three core business verticals, Delic Corp. is well positioned to capitalize on the sector’s continued growth trajectory. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• StraightUp Resources’ mission is to maximize shareholder wealth and value through mineral discoveries at projects with carefully analyzed potential, focused on the acquisition, development, and exploration of mineral resource properties in North America
• The company completed an IPO in March 2020 and has since acquired six properties in Canada and the United States (RLX NORTH, RLX SOUTH, BELANGER, FERDINAND, BEAR HEAD, WEST CAT MINE).
• Its Canadian properties are located in an area with a rich mining history and currently revealing a resurgence of gold-bearing deposits that were overlooked in the past
• Together with the recent acquisition of property in Nevada, StraightUp is positioning itself among companies of significant potential within this sector

StraightUp Resources (CSE: ST) is on a mission to maximize shareholder value and wealth through mineral discoveries at projects with robust potential, maintaining long-lasting partnerships, and continued focus on the acquisition, development, and exploration of mineral resource properties in North America. Since completing an initial public offering (“IPO”) in March last year and a non-brokered private placement a month later, the Sechelt, British Columbia-headquartered company embarked on a journey that has seen it acquire mining assets and conduct magnetic surveys and field examinations. The first in the series of acquisitions was the June 11, 2020 announcement that it had been granted the exclusive right and option to acquire certain unpatented mining claims comprising RLX North, RLX South, and Belanger Red Lake gold properties (https://ibn.fm/07JU2). Upon receiving exploration permits for the properties shortly thereafter, the company repatriated, re-logged, and assayed – compiled and reinterpreted – all available historical data for the Belanger property and subsequently announced results in February this year (https://ibn.fm/FbV4Y). In addition, a 43-101 Technical Report was also completed on the Belanger Property in June of this year. For its RLX North and RLX South assets (“RLX properties”), StraightUp Resources acquired a digital database of compilation and field exploration data for the properties in November 2020. The company then commenced the ground magnetic (“MAG”) survey in March this year and the Heli-borne MAG survey a few months later in July. With the latter MAG survey already complete, the company expects a final report early this month. “These projects are in the heart of the Red Lake Mining District, an area that is seeing a resurgence of gold-bearing deposits that were overlooked in the past,” commented StraightUp President and CEO Mark Brezer, following the completion of the Heli-borne MAG survey (https://ibn.fm/B2O97). “RLX North and South almost completely surround Great Bear Resources Sobel Project, and with our accumulated data from the region and upcoming MAG results, we can better pinpoint future drill programs.” This year also witnessed the second addition to StraightUp’s growing asset portfolio, when, in March, it acquired the Ferdinand Gold Property in Ontario. The property, situated near Red Lake, consists of 17 claims comprising 354 cells and encompassing 6,600 hectares. According to the press release detailing the terms of the acquisition, the Ferdinand Gold Property is situated within the prolific Uchi Subprovince, one of the most metal endowed greenstone belts in the world by square kilometer (https://ibn.fm/QcTwm). StraightUp, which in June initiated and received preliminary results on a high-resolution Heli-borne MAG survey on the Ferdinand Gold Property, has since started ground exploration. In describing this crucial milestone, Brezer noted that the exploration marks entry into an area that has been largely unexplored. “The Ferdinand Gold Project is within a crucial scale deformation zone that has never seen a drill hole. Results from our recent Heli-borne MAG survey have identified high priority targets and important geological structures for crews to begin prospecting, sampling, and mapping,” Brezer continued (https://ibn.fm/9lpBa). In July, StraightUp acquired the Bear Head Gold Property comprising 31 mining claims totaling 1,944 hectares in the Meen-Dempster Greenstone Belt, which hosts the Golden Patricia former gold mine that produced 620,000 ounces of gold at an average grade of 15.2 g/t from 1988-1997. According to Brezer, this acquisition complements the Ferdinand Gold Property. Last month, the company acquired the historic West Cat Mine in Nevada, US, marking its expansion into new mining districts as it continues to position itself among top-quality assets and companies. Through its focus on strategic acquisitions and exploration work, StraightUp Resources is making an indelible mark on the mining scene all the while maximizing shareholder wealth and value. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to ST are available in the company’s newsroom at https://ibn.fm/STR

• Palliative care focuses on providing end-of-life care for chronically ill patients
• Preliminary research suggests cannabis relieves pain, appetite loss, anxiety
• RYAH is the leader in volume-control technology for plant-based medicine
• RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data

With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is positioned to address the urgent need for cannabis-based solutions in palliative care. Palliative care is an emerging healthcare field that focuses on providing solutions that alleviate the suffering of patients with a chronic diagnosis, including cardiovascular disease, cancer, chronic respiratory disease, AIDS, and diabetes. While end-of-life care is not a curative approach, treatments provided to patients focus on improving quality of life and relieving symptoms such as pain, depression, anxiety, and appetite loss. The World Health Organization (“WHO”) states that only 14 percent of approximately 40 million people that need end-of-life care each year receive it (https://ibn.fm/Nt4zU). A growing body of research demonstrates that cannabis and cannabinoids help ease symptoms associated with many chronic diseases (https://ibn.fm/tJFnF). While the research is still ongoing, cannabis continues to be a physician-recommended option to alleviate suffering by relieving symptoms such as pain, anxiety, and loss of appetite. Accordingly, evidence suggests that cannabis can replace opioids or be used as a suitable cotreatment to reduce opioid load (https://ibn.fm/AzgTk), with 67 percent of oncologists reporting that medical cannabis was a helpful treatment in conjunction with standard pain management approaches (https://ibn.fm/67QXG). RYAH’s ecosystem of IoT products, including its volume-control devices, medicine-carrying components, and mobile applications, can provide a reliable way for researchers and clinicians to develop well-controlled environments to study the use of cannabis for palliative care. Accordingly, the company’s Smart Dry-Herb Dose-Measuring Inhaler is currently being used in one of the most extensive medical studies ever undertaken. Other devices to follow include a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage. The development of RYAH’s Data Ecosystem is part of the company’s goal of generating AI-powered models that can provide precision treatments for various diseases, including chronic conditions requiring end-of-life care. Along with delivering volume-controlled devices, RYAH’s technology stack includes QR tracking applications to track product formulations and dosing parameters, as well as mobile applications that can manage volumetric data and provide patient feedback. RYAH is dedicated to helping doctors and patients unlock the power of data to provide better patient outcomes. With its robust intellectual property portfolio, AI-powered technology, and suite of portable, cost-effective products, the company is positioned to capitalize on growth opportunities in the IoT and data intelligence sectors while providing critical volume-control solutions for the plant-based medical industry. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• USA CBD Expo will host their upcoming October conference at Chicago’s McCormick Place between October 28-30, 2021.
• Forming part of the nation’s largest CBD event series, the USA CBD Expo will cater to CBD industry newcomers and seasoned industry professionals alike
• The conference will play feature a series of keynote presentations and discussions delivered by some of the industry’s leading thinkers and innovators
• In addition, the Expo will also be host to over 500 of the industry’s largest and most pioneering brands who will showcase their diverse product ranges under a single roof

USA CBD Expo is set to host their upcoming conference in conjunction with presenting sponsor, 3Chi, the nation’s largest CBN and Delta-8 distributor, at Chicago’s McCormick Place on October 28-30, 2021. The event will mark a new iteration of the nation’s largest CBD event series, which will provide conference attendees with the unique opportunity to hear from over 50 expert speakers, visit hundreds of vendors, and network alongside thousands of their peers. The USA CBD Expo has long established a well-earned reputation as the United States’ largest dedicated CBD conference series, bringing together the entire CBD and Hemp industry within a single, comprehensive, and all-inclusive event. Having originally started with an exclusive focus on the global vaping community, the USA CBD Expo has expanded over the past several years, culminating in a series of all-encompassing, premier trade shows which seeks to provide delegates with a fun, thrilling experience that promotes business networking within the industry. The upcoming Expo, which has been designed to cater to CBD industry newcomers and seasoned industry professionals alike, will seek to introduce attendees to a carefully curated group of CEO’s, corporate leaders, and sector thought leaders who will delve deeper into the intricacies surrounding the industry through a series of educational seminars, keynote addresses, and workshops. Industry personalities in attendance at the conference will include the likes of Samm Macias and Nick Smeriglio, Angela Ardolino of CBD Dog Health; Asa Waldstein from the Supplement Advisory Group; Angela Boyce of Primo Gardens; and Jason Gann, star of Wilfred and representing Wilfred CBD, among a variety of other featured speakers. Seminars will focus on a wide array of topics, including providing attendees with an overview of changes within the commercial side of the CBD and hemp industry, current and future CBD market trends, health benefits, ongoing legalization efforts as well as medicinal use cases. Additionally, some of the scheduled talks include CBD for sexual wellness, psychedelics education, the power of medicinal mushroom extracts, information about delta-8 and its legality, among other diverse topics. In addition to its standout list of industry personalities and expert speakers, the USA CBD Expo will also bring together upwards of 500 of the industry’s largest and most pioneering brands under a single roof. Participants can explore and discover some of the CBD and hemp sector’s newest and most innovative products, ranging from edibles and beverages to cosmetics and pet products. Additional information about the USA CBD Expo, as well as details for registration, can be found at the USA CBD Expo website at https://usacbdexpo.com/

Date: October 29, 2021 Online Virtual Event Bitcoin Events is proud to announce the third edition of Crypto Fest, scheduled for October 29, 2021. This one-day online event will feature controversial speakers and discussions with a focus on Non-Fungible Tokens (“NFTs”) and Decentralized Finance (“DeFi”). This year’s event targets fintech professionals, cryptocurrency mining entities, retail and institutional investors, and crypto and NFT enthusiasts. It guarantees a jam-packed day with exciting keynotes, presentations, workshops, product exhibitions, competitions, entertainment and contentious topics that are specifically geared towards offering attendees value and the requisite knowledge to navigate through the crypto world. Over 2,500 attendees are expected to show up for the event. Additionally, over 30 global innovators and thought leaders in the blockchain and cryptocurrency industry will take the stage to discuss different topics and even engage in debates amongst each other. There will also be a Q&A session where the event’s speakers will answer attendees’ questions. Crypto Fest 2021 promises a great networking opportunity with some of the industry’s most progressive professionals across different industries including, but not limited to mining, trading, insurance, finance, software infrastructure, regulation, legal, auditing and investment, among others. The audience will learn everything about the different tools, techniques, and platforms available for effective crypto investment and trading, especially with the ongoing proliferation of alternative currencies. Through this event, attendees will discover how cryptocurrencies can enable financial inclusion and greater participation in the financial ecosystem. They will also understand the consumer demands of the future and learn how to develop strategies for successful cryptocurrency and blockchain implementation. The audience will explore different collaborations and even create new strategic partnerships at the available exhibition booths. The audiences’ chance to win prizes and giveaways from the event’s sponsors and partners is even more exciting. There will also be an after-party right after the main event where attendees will enjoy some music and interact even further with their colleagues and partners in the industry. Crypto Fest 2019 and 2020 were both successful in attendance and pushing the conversation around alternative currencies and blockchain. Bitcoin Events has made a name for itself as Africa’s leading blockchain and cryptocurrency event organizer since its inception in 2014. As such, Crypto Fest 2021 pledges to build on all the previous events and to take things a notch higher, creating more engagement and offering a platform through which individuals in the crypto and blockchain space can interact, learn and grow. This event guarantees value to attendees. With a lineup of world-class global speakers and specially-curated topics, attendees are guaranteed to leave with knowledge, contacts and ideas that will take their businesses to the next level. This has always been the goal with Crypto Fest, and this 2021 event promises to be no different.

• For those who want to be part of the virtual event, please register here for free (https://ibn.fm/5W1ac)
• Should you wish to exhibit at the event, visit our page here (https://ibn.fm/73PCQ)
• If you would like to become a speaker at the event, please submit your application here (https://ibn.fm/IPDxb)
• To sponsor the event, please visit (https://ibn.fm/whI98)

• Date: Nov. 8-9, 2021
• Venue: Adrienne Arsht Center for the Performing Arts, Miami
• Agenda: Two days of expert panels covering a variety of topics surrounding the psychedelics industry’s medicinal, corporate and regulatory impact and beyond
• Tickets and Registration Info: Visit https://microdose.buzz/wonderland/miami/

As the health and wellness industry evolves, a veritable flood of innovators searching for the next frontier in holistic product market opportunities has turned recently to the potential of entheogenic (psychedelic) substances long taboo under the umbrella of war-on-drugs regulations. In September, news that the federal government’s National Institute on Drug Abuse (“NIDA”) is providing a funding grant for a study into how psilocybin could help people quit smoking cigarettes showed the potential strength of the psychedelics reform movement (https://ibn.fm/gRbUg). Conference event series organizer Microdose’s Wonderland: Miami gathering promises to be the largest psychedelic medicine business event ever when it opens its doors Nov. 8-9 in Miami’s Adrienne Arsht Center for the Performing Arts, one of the largest performing arts centers in the United States (https://ibn.fm/L73Vg). During two days of panels covering subjects that range from the current state of regulatory acceptance of psychedelics and their uses to next-generation research and development, dozens of innovators and experts in the industry will address leading concerns for anyone interested in the sector. Former world heavyweight champion boxer Mike Tyson and two-time NBA Champion basketball player Lamar Odom will provide athletic celebrity to the event, with Tyson addressing neurological health and wellness and Odom talking on ketamine’s future possibilities. Microdose sponsors monthly events designed to promote the psychedelics industry and awareness of its financial potential. The company’s newsletter provides a continuous feed of news and updates on the industry’s businesses and marketplaces, merchandise and educational opportunities. The Wonderland event organizers have partnered with internationally award-winning design teams to make the in-person event unforgettable, using projection mapping technology to create an animated, living stage. A first set of annual awards, a competition to pitch to venture capitalists and the opportunity to obtain a need-based scholarship to Wonderland provide extra depth to the experience. Microdose anticipates an audience spanning more than 140 countries to experience the insights offered by panelists bookended by the University of California, San Francisco and Baltimore, Maryland’s Johns Hopkins University School of Medicine, with a wide array of corporate and non-profit interests on display. A second round of early-bird tickets are still available, as well as standard, business entry and VIP pricing. A virtual access pass is also available for participants who prefer to attend via the event’s livestream or review sessions that they may have initially missed. For further information on the November conference and to obtain tickets for the event, visit https://microdose.buzz/wonderland/miami/.

• Multi-State Operator Red White & Bloom Brands is a cannabis retail opportunity builder expanding via acquisitions to create a synergistic portfolio throughout North America
• The company recently completed strategic refinancing that reorganizes its debt under an agreement that matures in January 2023
• The company continues aiming to improve its EBITDA margins under a harmonious High Times brand throughout its retail stores in Michigan, Florida, and Illinois, and it continues to build additional opportunities in California, Arizona, Oklahoma, and Massachusetts
• North America is set to become the dominant producer market for cannabis, and Red White & Bloom’s multi-state operator efforts are positioning it to become one of the top names in the U.S. legal cannabis and hemp sector

Retail cannabis brand builder Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multi-state operator intent on becoming one of the top names in the U.S. legal cannabis and hemp sector, announced Sept. 27 the successful completion of refinancing that will replace $18.62 million in debentures plus accrued interest with a new principal amount that will be payable on the maturity date of Jan. 21, 2023 (https://ibn.fm/dfzJY). Red White & Bloom is a Canadian-based company working to build on its successes in United States markets through strategic brand acquisitions and partnerships. The company has closed or is in the process of closing on assets in Michigan, Illinois, Florida, Oklahoma, Massachusetts, and California. In September, Red White & Bloom announced a key element of that growth process with news that it has improved a Florida production facility, building it out to good manufacturing practice (“GMP”) standards as it takes aim at the Sunshine State’s growing market for edible cannabis derivatives (https://ibn.fm/HglMG). Forbes has reported that Florida is the third-largest cannabis market in the country by annual sales and the largest market for medical marijuana (https://ibn.fm/tDV1C). Despite the ongoing COVID-19 pandemic, Florida continues to be a huge draw for tourism and is becoming friendlier to cannabis-tolerant legislation, creating the potential for huge benefits for companies well situated to take advantage of the trend. And in Michigan, a focal point for Red White & Bloom’s development, the company received adult recreational use prequalification status last month and hopes to end the year with a big retail presence in the state (https://ibn.fm/JZ2TS). Red White & Bloom acquired exclusive rights to High Times-branded THC products in Michigan, Florida and Illinois last year as well as exclusive High Times naming rights for its retail outlets in those states, providing Red White & Bloom with the ability to harmonize all its stores with instant brand equity and expand its EBITDA margins (https://ibn.fm/30cI3). The company has built its footprint coast-to-coast, also establishing a presence in California, Arizona, Oklahoma, and Massachusetts. North America is set to become the dominant producer of cannabis, and in Canada cannabis retail outlets, producers, manufacturers, distributors and warehouses were declared to have “essential services” status during the COVID-19 pandemic by Alberta’s leadership, allowing business to proceed unhindered there. Cannabinoid drugs such as Marinol, Syndros, Cesamet, and Epidolex gained approval by the Food and Drug Administration for medicinal use in the United States, and 10 states have legalized psychoactive forms of cannabis for recreational drug use (https://ibn.fm/gBcbP). For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Hydrogen represents an energy-intensive production process, and is also a difficult element to contain, with high volatility requiring extreme amounts of pressure for storage
• FuelPositive’s carbon-free ammonia solves the problem of volatile hydrogen on its own, using ammonia as the carrier, allowing end-users to convert the green ammonia back to hydrogen and produce electricity using hydrogen fuel cells
• Carbon-free ammonia can also be used as a fuel on its own without being converted to pure hydrogen
• In a partnership with National Compressed Air, FuelPositive plans to finish prototype carbon-free ammonia production units by the end of 2021 and commence high-visibility pilot programs in 2022

The aviation industry accounts for up to 3% of man-made CO2 emissions and 12% of CO2 from transport. Aviation giant Boeing (NYSE: BA) has pledged to reduce net carbon emissions by 50% of its 2005 total by 2050. This announcement was a part of several aviation company pledges to move toward eventual net-zero carbon emissions by 2050. Last year, Airbus (Frankfurt: AIRG.F) announced the company’s intention to build a hydrogen-fueled plane by 2035 (https://ibn.fm/zUvdY). Hydrogen is the ultimate net-zero carbon emission goal, but it comes with its own set of challenges. Initial hydrogen production as a fuel source is energy-intensive, and the end product is highly volatile. Extreme levels of pressure are required to store hydrogen, and there is currently no viable distribution infrastructure. Solutions to the problems posed by hydrogen are years away from being available. Committed to clean energy solutions, Toronto-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) offers an answer to hydrogen production and distribution issues via its proprietary modular and scalable carbon-free ammonia (“NH3”) technology. Ammonia is the perfect carrier for hydrogen, and an end-user can convert green ammonia back to the hydrogen element to produce electricity in hydrogen fuel cells. In fact, not only does the production of FuelPositive’s carbon-free NH3 require much less energy than producing hydrogen on its own, but it stores 65% more hydrogen than highly compressed pure hydrogen. Carbon-free ammonia can also be used as a fuel source itself, without converting it back to hydrogen. The transportation industry (planes, trains, ships, trucks, etc.) can be converted to use carbon-free ammonia as a fuel source just as easily as they are converted from gasoline or diesel fuel to propane or natural gas. Using carbon-free ammonia for this purpose would also eliminate the need for highly polluting ammonia production facilities – as there are no CO2 emissions associated with the FuelPositive process. NH3 is already used as fertilizer in agriculture, but according to Clifford, farms can use FuelPositive’s technology to produce carbon-free ammonia for multiple purposes, including to power tractors and harvesters, to replace propane in crop-drying systems, and in general to reduce the sector’s reliance on existing fossil fuel and fertilizer supply chains, potentially shielding farmers from unexpected price hikes. Worldwide, farmers are plagued by various threats to the health of their crops and businesses, from pesticide-resistance to severe weather and overwhelming demand, and in the absence of innovation, they are forced to try and tackle these emerging threats with old, ineffective tools (https://ibn.fm/teqPr). FuelPositive’s carbon-free NH3 would offer the agriculture sector a much-needed innovative approach it is in dire need of, if it wants to remain functional and continue growing. Recently, FuelPositive’s CEO Ian Clifford appeared on the Stock2Me podcast to discuss how his company’s NH3 technology has the potential to change the overall energy landscape using an “environmentally sound and economically viable process.” Compared to the current NH3 synthesis technologies, which generate extremely high CO2 emissions, FuelPositive’s technology is entirely carbon-free, Clifford explained (https://ibn.fm/64SzC). The company is now in the process of commercializing its technology, with plans to roll out demonstration units and pilot projects in early 2022. In May 2021, FuelPositive announced a partnership with National Compressed Air (“NCA”) and is currently working to execute a detailed production plan to complete the prototype builds by the end of 2021. Upon completion of these prototype builds, FuelPositive will be able to confirm the potential that its carbon-free ammonia technology holds for numerous sectors. FuelPositive is targeting three primary segments – agriculture, transportation and energy storage, but will initially focus its demonstration programs on agriculture. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF